Cytori Therapeutics Inc Series S Warrant
CYTXZ
CYTXZ was delisted on the 23rd of July, 2019.
6 hedge funds and large institutions have $40K invested in Cytori Therapeutics Inc Series S Warrant in 2018 Q2 according to their latest regulatory filings, with 6 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JG
Jefferies Group
New York
|
+$38.1K |
| 2 |
CH
CVI Holdings
Wilmington,
Delaware
|
+$11.2K |
| 3 |
California Public Employees Retirement System
Sacramento,
California
|
+$8.94K |
| 4 |
Jane Street
New York
|
+$4.51K |
| 5 |
Creative Planning
Overland Park,
Kansas
|
+$700 |
Top Sellers
CYTXZ Hedge Fund Activity: Q2 2018 in Review
6 of the 4,385 institutional investors tracked by Wall St. Rank reported a position in Cytori Therapeutics Inc Series S Warrant (CYTXZ) for Q2 2018, worth a combined $40K.
Buyers outnumbered sellers: 6 funds opened new CYTXZ positions and 0 closed out — a net gain of 6 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Jefferies Group, opening a new position worth an estimated $38.1K.
- 6 institutional investors held Cytori Therapeutics Inc Series S Warrant (CYTXZ) as of Q2 2018, up from 0 in Q1 2018.
- Funds reported $40K of Cytori Therapeutics Inc Series S Warrant stock for Q2 2018.
- 6 funds opened new Cytori Therapeutics Inc Series S Warrant positions in Q2 2018 and 0 closed out, a net change of +6 holders.
- The largest Cytori Therapeutics Inc Series S Warrant buyer in Q2 2018 was Jefferies Group, an estimated $38.1K added.
Based on aggregated 13F filings for Q2 2018.